Read, discover and understand progress, achievements and outcomes of cancer research, education and clinical care delivered by the VCCC, our alliance members, supporters and partners.
From diagnosis to treatment, survivorship and palliative care, the experience of every patient with cancer is different; effects can be physical, psychological, financial and social.
Navigating through encompasses family, friends, medical professionals, health service staff and many others along the way.
Brain cancer kills more children in Australia than any other disease, but genetically engineered killer T-cells could be a game changer
“The brain is a very high stakes environment to be working in when it comes to the immune system, because the side effects of potential new treatments, like inflammation, can be devastating when in the brain.”
Immunologist Dr Misty Jenkins is talking about the difficulty of finding a cure for one of the deadliest of cancers – brain cancer.
The Victorian Comprehensive Cancer Centre (VCCC) welcomes the state government budget announcement; a wonderful investment in progressing cancer discovery and care.
Congratulations to the VCCC alliance members and sector collaborators on gaining the Victorian Government’s support for these important initiatives.
Cancer clinical trials predominantly focus on new therapies to control cancer. However, patients with cancer commonly experience symptoms not directly related to the cancer itself. These symptoms can have a significant impact on the patient’s quality of life, as well as that of family and carers.
Through the Victorian Comprehensive Cancer Centre (VCCC) Investigator-Initiated Trial Building Capability Program, the VCCC has announced funding for two new investigator-initiated clinical trials addressing the treatment of two significant symptoms in patients with cancer: changes in taste during chemotherapy and insomnia in the palliative care setting. A third trial is targeting treatments on a personalised, molecular level.
GP Dr Alia Kaderbhai is among the first doctors in Australia to undertake a Masters of Cancer Sciences, a new degree at the University of Melbourne.
‘I am committed to improving the lives of patients diagnosed with cancer, and want to develop new and innovative ways to provide better care,’ she told newsGP.
Dr Kaderbhai is also keenly aware of the rapidly evolving nature of cancer care, as treatments and technologies continually develop and improve – a process that is impacting on the role of the GP.
The approach of cancer specialists is usually to go hard with chemotherapy, using repeated courses, to try and obliterate the tumour — but the statistics show that for most cancers, that's eventually doomed to failure.
And the prognosis hasn't changed much in decades.
That's prompted some researchers to argue for a complete re-think oriented around the concept of game theory, which is about decision making in the face of an opponent of some kind.
Australian Institute of Health and Welfare (AIHW) report released
In 2019, the rate of new cancer cases in Australia is expected to reach 483 new cases per 100,000 people, while cancer-related deaths are expected to decrease to 159 per 100,000 people. From 1982 to 2019, thyroid cancer and liver cancer incidence rates increased more than for any other cancer. Although liver cancer survival has improved since 1982, with the increasing liver cancer incidence rate, liver cancer mortality rates also increased more than for any other cancer.
Prominent South Australian oncologist Professor Dorothy Keefe has been appointed the new chief executive of Cancer Australia.
Federal Health Minister Greg Hunt said the appointment came as ministerial board appointments in the health portfolio topped more than 50 per cent female for the first time.
This month began with a visit to the annual Lorne Cancer Conference. Congratulations to all who have shared in the 30-year history of the meeting, and to the organising committee for yet another successful event. It was great to see strong representation from throughout the alliance and to share conversations and learnings across the cancer spectrum.
Improve treatment standards and increase patient care knowledge
More than 6,000 patients with cancer in Victoria, nationally and internationally, will benefit from four new clinical trial projects to be supported by the Victorian Comprehensive Cancer Centre’s (VCCC) Investigator-Initiated Trial Capacity Building Program with an investment of $3.7 million.
Underpinned by three decades of scientific determination and collaboration
A new targeted treatment option for patients with Chronic Lymphocytic Leukaemia (CLL) will be available from 1 March 2019 through the Australian Pharmaceutical Benefits Scheme (PBS).
Major diseases have a severe impact on the quality of life for Australians and their families
Minister for Industry, Science and Technology of the Australian Government is providing more than $22 million for important early stage research that will lead to new interventions, cures and treatments of major diseases.
Parliamentary Secretary for Health Anthony Carbines today launched the University of Melbourne Master of Cancer Sciences Course, in partnership with the Victorian Comprehensive Cancer Centre Alliance.
A new specialist university Masters degree will upskill researchers and professionals working in the cancer field, and has been developed with the support of the Victorian Government.
The Albury-Wodonga Regional Cancer Centre Trust Fund has launched annual scholarships of up to $10,000 for the centre's nursing staff to keep them up to date with research and best practise. [paywall]
New type of super-precise radiotherapy promises to transform the way we treat certain types of lung cancer
When Maureen Chrul was diagnosed with inoperable stage-one lung cancer 10 years ago, she told her family she didn't have the patience or the ability to fight it.
Ms Chrul, who is now 76, had raised six children as a single mother after her husband died in an industrial accident in the 1970s, all while working many different roles in hospitals around the city.
This week many of you will have celebrated the success of friends and colleagues who were awarded an Australia Day honour.
Dr Belinda Yeo and Professor Bruce Mann have been appointed joint VCCC Research & Education Leads – Breast Cancer
The Research & Education Lead program is key to the VCCC’s endeavours to systematise collaboration across the alliance, and pivotal to turning the idea of integration of research, education and clinical care, into reality.
Many smokers are wary of going to the doctor when they develop respiratory symptoms, because they’re worried about getting ticked off for being a smoker in the first place.
That’s especially problematic because catching lung cancer early is key.
So how can health bodies get those at risk to see a doc earlier?
Projects target functional, physical, social and emotional challenges that accompany a diagnosis of cancer
Throughout her career, Professor Mei Krishnasamy has worked to improve the evidence base for cancer nursing care, particularly for people with rarer cancers.
Deaths rates from rectal cancer are predicted to increase almost 60 per cent in Australia by 2035, while many other countries are seeing death rates fall.
On the plus side, Australia's rates of colon cancer are expected to fall by around 50 per cent by 2035. Death rates for both colon and rectal cancer are expected to drop globally but the total number of deaths is expected to rise, due to population growth and ageing.
Capitalising on digital health technology
Patients with cancer living in regional and rural Victoria will soon have access to clinical trials, on their doorstep.
Range of initiatives now underway
Increasing clinical trials harmonisation and enhancing capability across alliance partner trial sites are key initiatives to improve benefits to patients and access to cancer clinical trials.
Imperative that the conference provides innovative content that reflects the breadth and depth of our partners and collaborators
The VCCC Research Conference provides a spotlight for Victorian cancer research discoveries, education achievements and clinical translation outcomes, as well as bringing together national and international experts.
I’m very pleased to wrap up the year with the news that the first cancer clinical trial implemented through the VCCC Teletrials Program has opened in Albury, Wodonga and Bendigo.
Helping Cancer Researchers Pinpoint The Issue
The Australian Cancer Research Foundation (ACRF) Translational Proteomic Facility is the first in Australia with the capability for protein-based assays that will complement the use of genomics in targeting cancer therapies.